B. Braun of America Inc. is excited to announce the appointment of two new members to its board of directors. Dr. Dorothee Bartels, a global leader in healthcare analytics, and Michael Reitermann, a technology and commercial expert, join the company to drive innovation and improve patient outcomes. With a focus on leveraging data and technology, B. Braun aims to deliver tailored therapies and solutions that help healthcare providers enhance patient care. Let's explore the backgrounds and expertise of these accomplished individuals.
Dr. Dorothee Bartels: A Leader in Healthcare Analytics
Learn about the extensive experience and expertise of Dr. Dorothee Bartels in using data analytics to improve healthcare outcomes.
Dr. Dorothee Bartels is a globally recognized business and scientific leader with a strong background in using data analytics to drive healthcare improvements. With her current role as Chief Digital Officer at Aetion, a global healthcare analytics company, and previous positions at UCB Biosciences and Alphabet, Dr. Bartels brings a wealth of knowledge and experience to the board of B. Braun.
Having served as the Corporate Head of Global Epidemiology at Boehringer Ingelheim and Chief Digital Science Officer at BI X, Dr. Bartels has a deep understanding of the importance of real-world evidence and digital sciences in shaping healthcare strategies. Her academic appointments at Hannover Medical School and McGill University further highlight her expertise in public health and epidemiology.
With Dr. Bartels' expertise in healthcare analytics, B. Braun aims to leverage data-driven insights to develop tailored therapies and solutions that improve patient outcomes. Her appointment to the board reinforces the company's commitment to innovation and technology in healthcare.
Michael Reitermann: Driving Technological Change and Innovation
Discover the background and accomplishments of Michael Reitermann, a global commercial and technology leader with a track record of driving change in the healthcare sector.
Michael Reitermann brings a wealth of experience in driving technological change and innovation to B. Braun. With his previous roles at Siemens Healthineers, including Chief Executive Officer of Siemens Healthcare Diagnostics and President of the North American commercial organization, Mr. Reitermann has demonstrated his ability to anticipate and respond to developing technologies in the healthcare industry.
As a member of the Managing Board at Siemens Healthineers, Mr. Reitermann was responsible for diagnostics, enterprise services, and global sales and service. His expertise in molecular imaging and healthcare diagnostics further strengthens B. Braun's focus on delivering cutting-edge solutions to healthcare providers.
With an MS in Industrial Engineering from the Technical University of Karlsruhe and an MBA from the University of British Columbia, Mr. Reitermann combines technical knowledge with business acumen. His appointment to the board will drive B. Braun's technological advancements and help the company become a leader in innovative healthcare solutions.
Conclusion
In conclusion, the appointment of Dr. Dorothee Bartels and Michael Reitermann to the board of B. Braun of America Inc. marks a significant step towards driving innovation and improving patient outcomes in healthcare. With Dr. Bartels' expertise in healthcare analytics and Mr. Reitermann's background in driving technological change, B. Braun is well-positioned to leverage data and technology to deliver tailored therapies and solutions.
By focusing on innovation and data-driven insights, B. Braun aims to enhance patient care and contribute to the advancement of the healthcare industry. The addition of these accomplished individuals to the board further strengthens the company's commitment to becoming a top innovative and customer-focused healthcare company.
